Curcumin treatment attenuates pain and enhances functional recovery after incision - PubMed (original) (raw)
Curcumin treatment attenuates pain and enhances functional recovery after incision
Peyman Sahbaie et al. Anesth Analg. 2014 Jun.
Abstract
Background: Acute pain after surgery remains moderate to severe for 20% to 30% of patients despite advancements in the use of opioids, adjuvant drugs, and regional anesthesia. Depending on the type of surgery, 10% to 50% of patients experience persistent pain postoperatively, and there are no established methods for its prevention. Curcumin (diferuloylmethane) is one of the phenolic constituents of turmeric that has been used in Eastern traditional medicine as an antiseptic, antioxidant, anti-inflammatory, and analgesic agent. It may be effective for treating postoperative pain.
Methods: We used the hindpaw incision model with C57BL/6 mice. Sensitization to mechanical and thermal stimuli as well as effects on edema and temperature were measured up to 7 days after surgery. Spontaneous pain after incision was assessed by using conditioned place preference (CPP), and alterations in gait function were assessed using multiparameter digital gait analysis.
Results: Curcumin (50 mg/kg) significantly reduced the intensity of mechanical and heat sensitization after hindpaw incision in mice. No effects of curcumin on baseline nociceptive thresholds were observed. Curcumin also reduced hindpaw swelling after incision, suggesting an anti-inflammatory effect. In addition, perioperative curcumin treatment attenuated hyperalgesic priming due to incision when mice were subsequently challenged with hindpaw prostaglandin E2 application. Furthermore, while vehicle-treated mice had evidence of spontaneous pain 48 hours after incision in the CPP paradigm, no evidence of ongoing pain was observed in the mice treated with curcumin. Likewise, hindpaw incision caused changes in several gait-related indices, but most of these were normalized in the curcumin-treated animals. The peri-incisional levels of several pronociceptive immune mediators including interleukin (IL)-1β, IL-6, tumor necrosis factor α, and macrophage inflammatory protein-1α were either not reduced or were even augmented 1 and 3 days after incision in curcumin-treated mice. The anti-inflammatory cytokine IL-10 was unchanged, while transforming growth factor-β levels were enhanced under the same conditions.
Conclusions: Our studies suggest that curcumin treatment is effective in alleviating incision-induced inflammation, nociceptive sensitization, spontaneous pain, and functional gait abnormalities. Augmented transforming growth factor-β production provides one possible mechanism. These preclinical findings demonstrate curcumin's potential as a preventative strategy in postoperative pain treatment.
Similar articles
- Epigenetic regulation of spinal CXCR2 signaling in incisional hypersensitivity in mice.
Sun Y, Sahbaie P, Liang DY, Li WW, Li XQ, Shi XY, Clark JD. Sun Y, et al. Anesthesiology. 2013 Nov;119(5):1198-208. doi: 10.1097/ALN.0b013e31829ce340. Anesthesiology. 2013. PMID: 23756451 - Curcumin inhibits the increase of labile zinc and the expression of inflammatory cytokines after traumatic spinal cord injury in rats.
Ni H, Jin W, Yuan B, Zhu T, Wang J, Jiang J, Liang W, Ma Z. Ni H, et al. J Surg Res. 2014 Apr;187(2):646-52. doi: 10.1016/j.jss.2013.12.023. Epub 2014 Jan 3. J Surg Res. 2014. PMID: 24484908 - Intravenous flurbiprofen axetil accelerates restoration of bowel function after colorectal surgery.
Xu Y, Tan Z, Chen J, Lou F, Chen W. Xu Y, et al. Can J Anaesth. 2008 Jul;55(7):414-22. doi: 10.1007/BF03016307. Can J Anaesth. 2008. PMID: 18591698 Clinical Trial. - Therapeutic potential of curcumin in major retinal pathologies.
Peddada KV, Brown A, Verma V, Nebbioso M. Peddada KV, et al. Int Ophthalmol. 2019 Mar;39(3):725-734. doi: 10.1007/s10792-018-0845-y. Epub 2018 Feb 5. Int Ophthalmol. 2019. PMID: 29404861 Review.
Cited by
- Epigenetic regulation of spinal cord gene expression contributes to enhanced postoperative pain and analgesic tolerance subsequent to continuous opioid exposure.
Sahbaie P, Liang DY, Shi XY, Sun Y, Clark JD. Sahbaie P, et al. Mol Pain. 2016 Apr 18;12:1744806916641950. doi: 10.1177/1744806916641950. Print 2016. Mol Pain. 2016. PMID: 27094549 Free PMC article. - Monoamine control of descending pain modulation after mild traumatic brain injury.
Sahbaie P, Irvine KA, Shi XY, Clark JD. Sahbaie P, et al. Sci Rep. 2022 Sep 29;12(1):16359. doi: 10.1038/s41598-022-20292-7. Sci Rep. 2022. PMID: 36175479 Free PMC article. - Pre-treatment with microRNA-181a Antagomir Prevents Loss of Parvalbumin Expression and Preserves Novel Object Recognition Following Mild Traumatic Brain Injury.
Griffiths BB, Sahbaie P, Rao A, Arvola O, Xu L, Liang D, Ouyang Y, Clark DJ, Giffard RG, Stary CM. Griffiths BB, et al. Neuromolecular Med. 2019 Jun;21(2):170-181. doi: 10.1007/s12017-019-08532-y. Epub 2019 Mar 21. Neuromolecular Med. 2019. PMID: 30900118 Free PMC article. - Mild Traumatic Brain Injury Causes Nociceptive Sensitization through Spinal Chemokine Upregulation.
Sahbaie P, Irvine KA, Liang DY, Shi X, Clark JD. Sahbaie P, et al. Sci Rep. 2019 Dec 20;9(1):19500. doi: 10.1038/s41598-019-55739-x. Sci Rep. 2019. PMID: 31863005 Free PMC article. - Autonomic Regulation of Nociceptive and Immunologic Changes in a Mouse Model of Complex Regional Pain Syndrome.
Sahbaie P, Li WW, Guo TZ, Shi XY, Kingery WS, Clark JD. Sahbaie P, et al. J Pain. 2022 Mar;23(3):472-486. doi: 10.1016/j.jpain.2021.09.009. Epub 2021 Oct 23. J Pain. 2022. PMID: 34699985 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources